BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 10022470)

  • 1. In vivo interleukin-2 gene therapy of established tumors with herpes simplex amplicon vectors.
    D'Angelica M; Karpoff H; Halterman M; Ellis J; Klimstra D; Edelstein D; Brownlee M; Federoff H; Fong Y
    Cancer Immunol Immunother; 1999 Jan; 47(5):265-71. PubMed ID: 10022470
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Efficient cotransduction of tumors by multiple herpes simplex vectors: implications for tumor vaccine production.
    Karpoff HM; Kooby D; D'Angelica M; Mack J; Presky DH; Brownlee MD; Federoff H; Fong Y
    Cancer Gene Ther; 2000 Apr; 7(4):581-8. PubMed ID: 10811476
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Specific organ gene transfer in vivo by regional organ perfusion with herpes viral amplicon vectors: implications for local gene therapy.
    Brooks AD; Ng B; Liu D; Brownlee M; Burt M; Federoff HJ; Fong Y
    Surgery; 2001 Mar; 129(3):324-34. PubMed ID: 11231461
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Combination therapy with suicide and cytokine genes for hepatic metastases of lung cancer.
    Kwong YL; Chen SH; Kosai K; Finegold M; Woo SL
    Chest; 1997 Nov; 112(5):1332-7. PubMed ID: 9367477
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Rapid production of interleukin-2-secreting tumor cells by herpes simplex virus-mediated gene transfer: implications for autologous vaccine production.
    Tung C; Federoff HJ; Brownlee M; Karpoff H; Weigel T; Brennan MF; Fong Y
    Hum Gene Ther; 1996 Dec; 7(18):2217-24. PubMed ID: 8953312
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cytokine gene transfer enhances herpes oncolytic therapy in murine squamous cell carcinoma.
    Wong RJ; Patel SG; Kim S; DeMatteo RP; Malhotra S; Bennett JJ; St-Louis M; Shah JP; Johnson PA; Fong Y
    Hum Gene Ther; 2001 Feb; 12(3):253-65. PubMed ID: 11177562
    [TBL] [Abstract][Full Text] [Related]  

  • 7. In vivo transfer of the human interleukin-2 gene: negative tumoricidal results in experimental brain tumors.
    Ram Z; Walbridge S; Heiss JD; Culver KW; Blaese RM; Oldfield EH
    J Neurosurg; 1994 Mar; 80(3):535-40. PubMed ID: 8113867
    [TBL] [Abstract][Full Text] [Related]  

  • 8. In situ retroviral-mediated gene transfer for the treatment of brain tumors in rats.
    Ram Z; Culver KW; Walbridge S; Blaese RM; Oldfield EH
    Cancer Res; 1993 Jan; 53(1):83-8. PubMed ID: 8380127
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Efficient gene transfer to human squamous cell carcinomas by the herpes simplex virus type 1 amplicon vector.
    Carew JF; Federoff H; Halterman M; Kraus DH; Savage H; Sacks PG; Schantz SP; Shah JP; Fong Y
    Am J Surg; 1998 Nov; 176(5):404-8. PubMed ID: 9874422
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Herpes vector-mediated delivery of marker genes to disseminated central nervous system tumors.
    Kramm CM; Rainov NG; Sena-Esteves M; Chase M; Pechan PA; Chiocca EA; Breakefield XO
    Hum Gene Ther; 1996 Feb; 7(3):291-300. PubMed ID: 8835217
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A novel approach to cancer therapy using an oncolytic herpes virus to package amplicons containing cytokine genes.
    Carew JF; Kooby DA; Halterman MW; Kim SH; Federoff HJ; Fong Y
    Mol Ther; 2001 Sep; 4(3):250-6. PubMed ID: 11545616
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Improved herpes simplex virus type 1 amplicon vectors for proportional coexpression of positron emission tomography marker and therapeutic genes.
    Jacobs AH; Winkeler A; Hartung M; Slack M; Dittmar C; Kummer C; Knoess C; Galldiks N; Vollmar S; Wienhard K; Heiss WD
    Hum Gene Ther; 2003 Feb; 14(3):277-97. PubMed ID: 12639307
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Combination vascular delivery of herpes simplex oncolytic viruses and amplicon mediated cytokine gene transfer is effective therapy for experimental liver cancer.
    Zager JS; Delman KA; Malhotra S; Ebright MI; Bennett JJ; Kates T; Halterman M; Federoff H; Fong Y
    Mol Med; 2001 Aug; 7(8):561-8. PubMed ID: 11591892
    [TBL] [Abstract][Full Text] [Related]  

  • 14. In situ generation of pseudotyped retroviral progeny by adenovirus-mediated transduction of tumor cells enhances the killing effect of HSV-tk suicide gene therapy in vitro and in vivo.
    Okada T; Caplen NJ; Ramsey WJ; Onodera M; Shimazaki K; Nomoto T; Ajalli R; Wildner O; Morris J; Kume A; Hamada H; Blaese RM; Ozawa K
    J Gene Med; 2004 Mar; 6(3):288-99. PubMed ID: 15026990
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Herpes simplex virus thymidine kinase gene therapy for rat malignant brain tumors.
    Vincent AJ; Vogels R; Someren GV; Esandi MC; Noteboom JL; Avezaat CJ; Vecht C; Bekkum DW; Valerio D; Bout A; Hoogerbrugge PM
    Hum Gene Ther; 1996 Jan; 7(2):197-205. PubMed ID: 8788170
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antitumor activity and reporter gene transfer into rat brain neoplasms inoculated with herpes simplex virus vectors defective in thymidine kinase or ribonucleotide reductase.
    Boviatsis EJ; Scharf JM; Chase M; Harrington K; Kowall NW; Breakefield XO; Chiocca EA
    Gene Ther; 1994 Sep; 1(5):323-31. PubMed ID: 7584098
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Efficacy of herpes simplex virus thymidine kinase in combination with cytokine gene therapy in an experimental metastatic breast cancer model.
    Majumdar AS; Zolotorev A; Samuel S; Tran K; Vertin B; Hall-Meier M; Antoni BA; Adeline E; Philip M; Philip R
    Cancer Gene Ther; 2000 Jul; 7(7):1086-99. PubMed ID: 10917212
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Gene transfer into hepatocytes mediated by helper virus-free HSV/AAV hybrid vectors.
    Fraefel C; Jacoby DR; Lage C; Hilderbrand H; Chou JY; Alt FW; Breakefield XO; Majzoub JA
    Mol Med; 1997 Dec; 3(12):813-25. PubMed ID: 9440115
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Therapeutic efficiency of IL-2 gene transduced tumor vaccine for head and neck carcinoma.
    Mizuno H; Yanoma S; Nishimura G; Hattori S; Ito T; Okudera K; Tsukuda M
    Cancer Lett; 2000 May; 152(2):175-85. PubMed ID: 10773410
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Disabled infectious single-cycle herpes simplex virus as an oncolytic vector for immunotherapy of colorectal cancer.
    Todryk S; McLean C; Ali S; Entwistle C; Boursnell M; Rees R; Vile R
    Hum Gene Ther; 1999 Nov; 10(17):2757-68. PubMed ID: 10584922
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.